Edgewise Therapeutics (EWTX) announced positive updates from the ongoing CIRRUS-HCM, Phase 2 clinical trial of EDG-7500, a novel oral, selective, ...

Coffee and the caffeine in it were long-considered a risk for patients with certain heart conditions. But a recent study ...

The area addressed is vast—a single Medline search with the term “molecular mechanisms atrial fibrillation” revealed 611 papers. We have therefore chosen to focus on clinically relevant mechanisms ...

Objective Left atrial appendage (LAA) thrombus has heretofore been considered a contraindication to percutaneous LAA closure (LAAC). Data regarding its management are very limited. The aim of this ...

As the holiday season ramps up with parties, big meals and celebratory drinks, doctors are reminding men not to ignore their ...

Vektor Medical receives US FDA 510(k) clearance for its next-generation vMap technology to enhance connectivity: San Diego Saturday, December 13, 2025, 17:00 Hrs [IST] Vektor Medi ...

BSX builds momentum in PFA as FARAPULSE posts strong growth, and new trial results and expanded FDA labeling boost its AF treatment push.

Vektor Medical, a medical technology company transforming cardiac arrhythmia care, today announced it has received FDA 510(k) clearance for its next-generation vMap® technology. The clearance expands ...

Contrary to old beliefs, a new study suggests daily coffee might help manage irregular heart rhythms like AFib. Researchers found participants drinkin ...

Blues Traveler frontman John Popper has had his share of health issues through the years, but what he faced in 2025 … well, the singer told Rolling Stone that it nearly killed him. And the way he got ...